Remdesivir is produced by Gilead Sciences. The drug was initially developed as a treatment for the Ebola virus and clinical trials have showed promise against the novel coronavirus.
Emory conducted a trial of the drug in recent weeks, and the medication was granted an emergency use authorization by the FDA. But it has not gained full approval.
The state has received a second allotment, which the release said is much larger. That distribution, which is still being planned, will happen in the coming days.